Runx Transcription Factors Repress Human and Murine c-Myc Expression in a DNA-Binding and C-Terminally Dependent Manner

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Jacobs, Paejonette T ^a   Cao, Li ^b   Samon, Jeremy B ^c   Kane, Christyne A ^a   Hedblom, Emmett E ^a   Bowcock, Anne ^b   Telfer, Janice C ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Quntiles Medical Education Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYBRID PROTEIN; MYC PROTEIN; TRANSCRIPTION FACTOR RUNX;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLASMID; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA; DNA PRIMERS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; HEMATOPOIETIC STEM CELLS; HUMANS; JURKAT CELLS; MICE; MUTAGENESIS; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS;

EID: 84880420709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069083     Document Type: Article

References (94)

1. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, et al. (1993) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A 90: 6859-6863.
2. Wang SW, Speck NA, (1992) Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol 12: 89-102. PubMed: 1309596.
3. Erickson P, Gao J, Chang KS, Look T, Whisenant E, et al. (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80: 1825-1831. PubMed: 1391946.
4. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, et al. (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A 88: 10431-10434. doi:10.1073/pnas.88.23.10431. PubMed: 1720541.
5. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA, (2009) Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457: 887-891. doi:10.1038/nature07619. PubMed: 19129762.
6. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR, (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330. doi:10.1016/S0092-8674(00)80986-1. PubMed: 8565077.
7. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, et al. (1996) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A 93: 3444-3449. doi:10.1073/pnas.93.8.3444. PubMed: 8622955.
8. Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, et al. (2004) AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 10: 299-304. doi:10.1038/nm997. PubMed: 14966519.
9. Ichikawa M, Goyama S, Asai T, Kawazu M, Nakagawa M, et al. (2008) AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol 180: 4402-4408. PubMed: 18354160.
10. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, et al. (2005) Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106: 494-504. doi:10.1182/blood-2004-08-3280. PubMed: 15784726.
11. Putz G, Rosner A, Nuesslein I, Schmitz N, Buchholz F, (2006) AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 25: 929-939. doi:10.1038/sj.onc.1209136. PubMed: 16247465.
12. Speck NA, Stacy T, Wang Q, North T, Gu TL, et al. (1999) Core-binding factor: a central player in hematopoiesis and leukemia. Cancer Res 59: 1789s-1793s. PubMed: 10197598.
13. Daga A, Tighe JE, Calabi F, (1992) Leukaemia/Drosophila homology. Nature 356: 484. doi:10.1038/356484a0. PubMed: 1560822.
14. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, et al. (1993) The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet 9: 338-341.
15. Meyers S, Downing JR, Hiebert SW, (1993) Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13: 6336-6345. PubMed: 8413232.
16. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, et al. (1994) AML1, AML2, and AML3, the Human Members of the runt domain Gene-Family: cDNA Structure, Expression, and Chromosomal Localization. Genomics 23: 425-432. doi:10.1006/geno.1994.1519. PubMed: 7835892.
17. Bae S-C, Takahashi E-i, Zhang YW, Ogawa E, Shigesada K, et al. (1995) Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene 159: 245-248. doi:10.1016/0378-1119(95)00060-J. PubMed: 7622058.
18. Bae SC, Ogawa E, Maruyama M, Oka H, Satake M, et al. (1994) PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 14: 3242-3252. PubMed: 8164679.
19. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, et al. (1993) Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8: 809-814. PubMed: 8437866.
20. Kanno T, Kanno Y, Chen LF, Ogawa E, Kim WY, et al. (1998) Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol 18: 2444-2454. PubMed: 9566865.
21. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, et al. (1997) Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A 94: 6746-6751. doi:10.1073/pnas.94.13.6746. PubMed: 9192636.
22. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, et al. (1998) Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A 95: 11590-11595. doi:10.1073/pnas.95.20.11590. PubMed: 9751710.
23. Speck NA, Gilliland DG, (2002) Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: 502-513. doi:10.1038/nrc840. PubMed: 12094236.
24. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, et al. (2002) Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A 99: 8048-8053. doi:10.1073/pnas.112664499. PubMed: 12060751.
25. Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ, (1994) Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol 14: 840-850. PubMed: 8264651.
26. Giese K, Kingsley C, Kirshner JR, Grosschedl R, (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995-1008. doi:10.1101/gad.9.8.995. PubMed: 7774816.
27. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, et al. (1998) Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol 18: 3915-3925. PubMed: 9632776.
28. Bruhn L, Munnerlyn A, Grosschedl R, (1997) ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev 11: 640-653. doi:10.1101/gad.11.5.640. PubMed: 9119228.
29. Gu T-L, Goetz TL, Graves BJ, Speck NA, (2000) Auto-Inhibition and Partner Proteins, Core-Binding Factor beta (CBFbeta) and Ets-1, Modulate DNA Binding by CBFalpha 2 (AML1). Mol Cell Biol 20: 91-103. doi:10.1128/MCB.20.1.91-103.2000. PubMed: 10594012.
30. McLarren KW, Theriault FM, Stifani S, (2001) Association with the Nuclear Matrix and Interaction with Groucho and RUNX Proteins Regulate the Transcription Repression Activity of the Basic Helix Loop Helix Factor Hes1. J Biol Chem 276: 1578-1584. doi:10.1074/jbc.M007629200. PubMed: 11035023.
31. Javed A, Guo B, Hiebert S, Choi JY, Green J, et al. (2000) Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci 113: 2221-2231. PubMed: 10825294.
32. Ahn M-Y, Huang G, Bae S-C, Wee H-J, Kim W-Y, et al. (1998) Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO(MTG8). Proc Natl Acad Sci USA 95: 1812-1817. doi:10.1073/pnas.95.4.1812. PubMed: 9465099.
33. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, et al. (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16: 1349-1355. PubMed: 8657108.
34. Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP, (1997) Groucho-dependent and-independent repression activities of Runt domain proteins. Mol Cell Biol 17: 5581-5587. PubMed: 9271433.
35. Bruno L, Mazzarella L, Hoogenkamp M, Hertweck A, Cobb BS, et al. (2009) Runx proteins regulate Foxp3 expression. J Exp Med 206: 2329-2337. doi:10.1084/jem.20090226. PubMed: 19841090.
36. Telfer JC, Hedblom EE, Anderson MK, Laurent MN, Rothenberg EV, (2004) Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J Immunol 172: 4359-4370. PubMed: 15034051.
37. Telfer JC, Rothenberg EV, (2001) Expression and function of a stem cell promoter for the murine CBFalpha2 gene: distinct roles and regulation in natural killer and T cell development. Dev Biol 229: 363-382. doi:10.1006/dbio.2000.9991. PubMed: 11203699.
38. Yannoutsos N, Barreto V, Misulovin Z, Gazumyan A, Yu W, et al. (2004) A cis element in the recombination activating gene locus regulates gene expression by counteracting a distant silencer. Nat Immunol 5: 443-450. doi:10.1038/ni1053. PubMed: 15021880.
39. Melnikova IN, Crute BE, Wang S, Speck NA, (1993) Sequence specificity of the core-binding factor. J Virol 67: 2408-2411. PubMed: 8445737.
40. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, et al. (1993) Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194: 314-331. doi:10.1006/viro.1993.1262. PubMed: 8386878.
41. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, et al. (1993) Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13: 3324-3339. PubMed: 8497254.
42. Tang YY, Shi J, Zhang L, Davis A, Bravo J, et al. (2000) Energetic and functional contribution of residues in the core binding factor beta (CBFbeta) subunit to heterodimerization with CBFalpha. J Biol Chem 275: 39579-39588. doi:10.1074/jbc.M007350200. PubMed: 10984496.
43. Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, et al. (2001) Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 20: 723-733. doi:10.1093/emboj/20.4.723. PubMed: 11179217.
44. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, et al. (1990) Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 64: 4808-4819. PubMed: 2168969.
45. Bravo J, Li Z, Speck NA, Warren AJ, (2001) The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp. Nat Struct Biol 8: 371-378. doi:10.1038/86264. PubMed: 11276260.
46. Li D, Sinha KK, Hay MA, Rinaldi CR, Saunthararajah Y, et al. (2007) RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function. J Biol Chem 282: 13542-13551. doi:10.1074/jbc.M700074200. PubMed: 17355962.
47. Li Z, Yan J, Matheny CJ, Corpora T, Bravo J,et al (2003) Energetic contribution of residues in the Runx1 Runt domain to DNA binding. J Biol Chem 278: 33088-33096. doi:10.1074/jbc.M303973200. PubMed: 12807882.
48. Osato M, (2004) Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 23: 4284-4296. doi:10.1038/sj.onc.1207779. PubMed: 15156185.
49. Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, et al. (2009) AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood 114: 5352-5361. doi:10.1182/blood-2009-05-223784. PubMed: 19808697.
50. Warren AJ, Bravo J, Williams RL, Rabbitts TH, (2000) Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta. EMBO J 19: 3004-3015. doi:10.1093/emboj/19.12.3004. PubMed: 10856244.
51. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, et al. (2008) Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 3: 611-624. doi:10.1016/j.stem.2008.09.005. PubMed: 19041778.
52. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, et al. (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18: 2747-2763. doi:10.1101/gad.313104. PubMed: 15545632.
53. Reavie L, Della Gatta G, Crusio K, Aranda-Orgilles B, Buckley SM, et al. (2010) Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex. Nat Immunol 11: 207-215. doi:10.1038/ni.1839. PubMed: 20081848.
54. Grandori C, Cowley SM, James LP, Eisenman RN, (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699. doi:10.1146/annurev.cellbio.16.1.653. PubMed: 11031250.
55. Eisenman RN, (2001) Deconstructing myc. Genes Dev 15: 2023-2030. doi:10.1101/gad928101. PubMed: 11511533.
56. Knoepfler PS, (2007) Myc goes global: new tricks for an old oncogene. Cancer Res 67: 5061-5063. doi:10.1158/0008-5472.CAN-07-0426. PubMed: 17545579.
57. Nilsson JA, Cleveland JL, (2003) Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007-9021. doi:10.1038/sj.onc.1207261. PubMed: 14663479.
58. Lin CY, Lovén J, Rahl PB, Paranal RM, Burge CB, et al. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67. doi:10.1016/j.cell.2012.08.026. PubMed: 23021215.
59. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. doi:10.1016/j.cell.2006.07.024. PubMed: 16904174.
60. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K, (2008) Induced pluripotent stem cells generated without viral integration. Science 322: 945-949. PubMed: 18818365.
61. Kelly K, Cochran BH, Stiles CD, Leder P, (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610. doi:10.1016/0092-8674(83)90092-2. PubMed: 6606489.
62. Jones TR, Cole MD, (1987) Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences. Mol Cell Biol 7: 4513-4521. PubMed: 3325826.
63. Rabbitts PH, Forster A, Stinson MA, Rabbitts TH, (1985) Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability. EMBO J 4: 3727-3733. PubMed: 4092694.
64. Sears R, Leone G, DeGregori J, Nevins JR, (1999) Ras enhances Myc protein stability. Mol Cell 3: 169-179. doi:10.1016/S1097-2765(00)80308-1. PubMed: 10078200.
65. Dani C, Blanchard JM, Piechaczyk M, El Sabouty S, Marty L, et al. (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci U S A 81: 7046-7050. doi:10.1073/pnas.81.22.7046. PubMed: 6594679.
66. Wotton S, Stewart M, Blyth K, Vaillant F, Kilbey A, et al. (2002) Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. Cancer Res 62: 7181-7185. PubMed: 12499254.
67. Blyth K, Slater N, Hanlon L, Bell M, Mackay N, et al. (2009) Runx1 promotes B-cell survival and lymphoma development. Blood Cells Mol Dis 43: 12-19. doi:10.1016/j.bcmd.2009.01.013. PubMed: 19269865.
68. Cameron ER, Blyth K, Hanlon L, Kilbey A, Mackay N, et al. (2003) The Runx genes as dominant oncogenes. Blood Cells Mol Dis 30: 194-200. doi:10.1016/S1079-9796(03)00031-7. PubMed: 12732183.
69. Wang F, Herzig C, Ozer D, Baldwin CL, Telfer JC, (2009) Tyrosine phosphorylation of scavenger receptor cysteine-rich WC1 is required for the WC1-mediated potentiation of TCR-induced T-cell proliferation. Eur J Immunol 39: 254-266. doi:10.1002/eji.200838472. PubMed: 19130552.
70. Dunning MJ, Smith ML, Ritchie ME, Tavaré S, (2007) beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23: 2183-2184. doi:10.1093/bioinformatics/btm311. PubMed: 17586828.
71. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80. PubMed: 15461798.
72. R Development Core Team (2009) R: A Language and Environment for Statistical Computing. Austria: Vienna.
73. Smyth GK, (2005) Limma: linear models for microarray data. In: Gentleman RC, Carey VJ, Dudoit S, Irizarry R, Huber W, eds. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer Verlag. pp. pp. 397-420.
74. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 57: 289-300.
75. Klampfer L, Zhang J, Zelenetz AO, Uchida H, Nimer SD, (1996) The AML1/ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci USA 93: 14059-14064. doi:10.1073/pnas.93.24.14059. PubMed: 8943060.
76. Wargnier A, Legros-Maida S, Bosselut R, Bourge JF, Lafaurie C, et al. (1995) Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci U S A 92: 6930-6934. doi:10.1073/pnas.92.15.6930. PubMed: 7624346.
77. Becker-Hapak M, McAllister SS, Dowdy SF, (2001) TAT-mediated protein transduction into mammalian cells. Methods 24: 247-256. doi:10.1006/meth.2001.1186. PubMed: 11403574.
78. Becker-Hapak M, Dowdy SF, (2003) Protein transduction: generation of full-length transducible proteins using the TAT system. Curr Protoc Cell Biol Chapter 20Unit 20.2: Unit 20.22. PubMed: 18228426.
79. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, et al. (2003) In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 9: 1428-1432. doi:10.1038/nm951. PubMed: 14578881.
80. Huang C-H, Chen P-M, Lu T-C, Kung W-M, Chiou T-J, et al. (2010) Purified recombinant TAT-homeobox B4 expands CD34(+) umbilical cord blood and peripheral blood progenitor cells ex vivo. Tissue Eng C Methods 16: 487-496. doi:10.1089/ten.tec.2009.0163. PubMed: 19686058.
81. Kaiserman D, Bird PI, (2010) Control of granzymes by serpins. Cell Death Differ 17: 586-595. doi:10.1038/cdd.2009.169. PubMed: 19893573.
82. Bladergroen BA, Meijer CJLM, ten Berge RL, Hack CE, Muris JJF, et al. (2002) Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99: 232-237. doi:10.1182/blood.V99.1.232. PubMed: 11756176.
83. Jiang W, Chai NR, Maric D, Bielekova B, (2011) Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis. J Immunol 187: 781-790. doi:10.4049/jimmunol.1100789. PubMed: 21666061.
84. Durst KL, Hiebert SW, (2004) Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23: 4220-4224. doi:10.1038/sj.onc.1207122. PubMed: 15156176.
85. Allen RD 3rd, Kim HK, Sarafova SD, Siu G, (2001) Negative regulation of CD4 gene expression by a HES-1-c-Myb complex. Mol Cell Biol 21: 3071-3082. doi:10.1128/MCB.21.9.3071-3082.2001. PubMed: 11287612.
86. Brabletz T, Jung A, Hlubek F, Löhberg C, Meiler J, et al. (1999) Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol 11: 1701-1708. doi:10.1093/intimm/11.10.1701. PubMed: 10508188.
87. Egawa T, Littman DR, (2011) Transcription factor AP4 modulates reversible and epigenetic silencing of the Cd4 gene. Proc Natl Acad Sci U S A 108: 14873-14878. doi:10.1073/pnas.1112293108. PubMed: 21873191.
88. Kim HK, Siu G, (1998) The notch pathway intermediate HES-1 silences CD4 gene expression. Mol Cell Biol 18: 7166-7175. PubMed: 9819403.
89. Taniuchi I, Sunshine MJ, Festenstein R, Littman DR, (2002) Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol Cell 10: 1083-1096. doi:10.1016/S1097-2765(02)00735-9. PubMed: 12453416.
90. Jung P, Menssen A, Mayr D, Hermeking H, (2008) AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A 105: 15046-15051. doi:10.1073/pnas.0801773105. PubMed: 18818310.
91. Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, et al. (2000) A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275: 651-656. doi:10.1074/jbc.275.1.651. PubMed: 10617663.
92. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, et al. (1996) CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16: 1231-1240. PubMed: 8622667.
93. Martinez P, Thanasoula M, Carlos AR, Gómez-López G, Tejera AM, et al. (2010) Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 12: 768-780. doi:10.1038/ncb2081. PubMed: 20622869.
94. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006) TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34: D108-D110. doi:10.1093/nar/gkj143. PubMed: 16381825.